Cardiac magnetic resonance follow-up of COVID-19 vaccine associated acute myocarditis

被引:8
|
作者
Kravchenko, Dmitrij [1 ,2 ]
Isaak, Alexander [1 ,2 ]
Mesropyan, Narine [1 ,2 ]
Bischoff, Leon M. [1 ,2 ]
Pieper, Claus C. [1 ]
Attenberger, Ulrike [1 ]
Kuetting, Daniel [1 ,2 ]
Zimmer, Sebastian [1 ,3 ]
Hart, Christopher [1 ,4 ]
Luetkens, Julian A. [1 ,2 ]
机构
[1] Univ Hosp Bonn, Dept Diagnost & Intervent Radiol, Bonn, Germany
[2] Univ Hosp Bonn, Quant Imaging Lab Bonn, Bonn, Germany
[3] Univ Hosp Bonn, Dept Internal Med Cardiol 2, Bonn, Germany
[4] Univ Hosp Bonn, Dept Pediat Cardiol, Bonn, Germany
来源
关键词
cardiac magnetic resonance; myocarditis; COVID-19; vaccination; follow-up; MR;
D O I
10.3389/fcvm.2022.1049256
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundMass COVID-19 vaccination campaigns have helped impede the COVID-19 pandemic. In rare cases, some vaccines have led to vaccine associated myocarditis in a specific subset of the population, usually young males. Cardiac magnetic resonance (CMR) can reliably diagnose vaccine associated myocarditis, but follow-up data of CMR proven acute myocarditis is scarce. Materials and methodsNine patients with acute vaccine associated myocarditis underwent baseline and follow-up CMR examinations and were compared to baseline parameters at initial presentation and to a group of 20 healthy controls. CMR protocol included functional assessment, T1 and T2 mapping, T2 signal intensity ratio, strain feature tracking, and late gadolinium enhancement (LGE). ResultsMyocarditis patients (n = 9, aged 24 +/- 6 years, 8 males) underwent CMR follow-up after an average of 5.8 +/- 4.3 months. All patients showed a complete resolution of visual myocardial edema while also demonstrating a reduction in overall LGE extent from baseline to follow-up (4.2 +/- 2.1 vs. 0.9 +/- 0.8%, p < 0.001), although visual LGE was still noted in all patients. Left ventricular ejection fraction was normal at baseline and at follow-up (58 +/- 6 vs. 62 +/- 4%, p = 0.10) as well as compared to a healthy control group (60 +/- 4%, p = 0.24). T1 (1024 +/- 77 vs. 971 +/- 34 ms, p = 0.05) and T2 relaxations times (57 +/- 6 vs. 51 +/- 3 ms, p = 0.03) normalized at follow-up. Most patients reported a resolution of clinical symptoms, while two (22%) reported new onset of exertional dyspnea. ConclusionPatients with COVID-19 vaccine associated acute myocarditis showed a complete, uncomplicated resolution of myocardial inflammation on follow-up CMR, which was associated with a near complete resolution of symptoms. Minor, residual myocardial scarring was present on follow-up LGE imaging. The long-term implications of the remaining myocardial scar-tissue after vaccine associated myocarditis remain unknown warranting further studies.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Cardiovascular Magnetic Resonance Imaging Patterns of Acute Covid-19 Vaccine Associated Myocarditis in Young Male Patients
    Evertz, Ruben
    Schulz, Alexander
    Lange, Torben
    Backhaus, Soeren J.
    Vollmann, Dirk
    Kowallick, Johannes
    von Haehling, Stephan
    Hasenfuss, Gerd
    Schuster, Andreas
    CIRCULATION, 2022, 146
  • [22] UTILITY OF CARDIAC MAGNETIC RESONANCE FOR INITIAL AND FOLLOW-UP EVALUATION OF A PATIENT WITH COMPLICATED ACUTE MYOCARDITIS
    Mariani, Andrea
    Scatteia, Alessandra
    Frecentese, Francesca
    Pascale, Carmine Emanuele
    Russo, Giuseppe
    Esposito, Giovanni
    Dellegrottaglie, Santo
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
  • [23] Optimal Timing and Prognostic Value of Follow-Up Cardiac Magnetic Resonance in Patients With Acute Myocarditis
    Ciabatti, Michele
    Camporeale, Antonia
    Tavanti, Valentina
    Saletti, Elisa
    Felici, Massimo
    Martinese, Lucia
    Chioccioli, Marco
    Sabini, Alessandra
    Lombardi, Massimo
    Pieroni, Maurizio
    Bolognese, Leonardo
    CIRCULATION, 2022, 146
  • [24] Cardiovascular magnetic resonance imaging and clinical follow-up in patients with clinically suspected myocarditis after COVID-19 vaccination
    Talib, Norain
    Fronza, Matteo
    Marschner, Constantin Arndt
    Thavendiranathan, Paaladinesh
    Karur, Gauri Rani
    Hanneman, Kate
    JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2024, 26 (01)
  • [25] Cardiac Magnetic Resonance Imaging Findings and Clinical Features of COVID-19 Vaccine-Associated Myocarditis, Compared With Those of Other Types of Myocarditis
    Kim, Sang Gyun
    Lee, Jeong Yeop
    Jeong, Won Gi
    Lee, Jong Eun
    Kim, Yun-Hyeon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2024, 39 (04)
  • [26] Cardiac magnetic resonance findings in acute and post-acute COVID-19 patients with suspected myocarditis
    Palmisano, Anna
    Vignale, Davide
    Bruno, Elisa
    Peretto, Giovanni
    De Luca, Giacomo
    Campochiaro, Corrado
    Tomelleri, Alessandro
    Agricola, Eustachio
    Montorfano, Matteo
    Esposito, Antonio
    JOURNAL OF CLINICAL ULTRASOUND, 2023, 51 (04) : 613 - 621
  • [27] Long-term follow-up of cardiac magnetic resonance imaging in myocarditis following messenger ribonucleic acid COVID-19 vaccination: a case report
    Kittichokechai, Pakaparn
    Seripanu, Panupong
    Laksomya, Thanakorn
    EUROPEAN HEART JOURNAL-CASE REPORTS, 2023, 7 (05)
  • [28] Baseline and Follow-Up Cardiac Magnetic Resonance Imaging Findings in Children with Acute Myocarditis and Factors Associated with Late Gadolinium Enhancement
    Yukcu, Bekir
    Aydemir, Merve Maze
    Balci, Mehmet
    Kanyilmaz, Mehmet
    Turkvatan, Aysel
    Gokalp, Selman
    Guzeltas, Alper
    Atik, Sezen Ugan
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (01)
  • [29] COVID-19 myocarditis cardiac magnetic resonance findings in symptomatic patients
    Altay, Sedat
    ACTA RADIOLOGICA, 2022, 63 (11) : 1475 - 1480
  • [30] Fulminant myocarditis with COVID-19 infection having normal C-reactive protein and serial magnetic resonance follow-up
    Usui, Eisuke
    Nagaoka, Eiki
    Ikeda, Hiroshi
    Ohmori, Mari
    Tao, Susumu
    Yonetsu, Taishi
    Maejima, Yasuhiro
    Arai, Hirokuni
    Amemiya, Kisaki
    Ikeda, Yoshihiko
    Sasano, Tetsuo
    ESC HEART FAILURE, 2023, 10 (02): : 1426 - 1430